Forresters are pleased to announce their latest hire and new partner, Thomas Böhmer, who recently joined the team in Munich.
Thomas is a German and European Patent Attorney with extensive experience in the life sciences field. He has joined Forresters from his most recent role as the Head of IP for Pieris Pharmaceuticals, a publicly listed clinical-stage biotech company based in Boston and the greater Munich metropolitan area. Prior to this position, Thomas spent the first thirteen years of his career in two patent law firms in Munich.
In addition to bolstering Forresters’ Munich office team, Thomas also brings a wealth of expertise to the life sciences practice as a whole. With a technical background in biochemistry, Thomas has a great deal of experience in prosecuting, defending and attacking patents related to a wide variety of technical areas, with a particular focus on protein, peptide and mRNA therapeutics as well as personalised medicine.
In his new role as part of the team in Munich, Thomas will be involved in a variety of patent drafting, prosecution and opposition matters before the EPO and internationally.
Thomas told us: “I have been watching Forresters‘ development for a very long time, and I am now super happy to be a part of it and to further strengthen its life sciences presence in Munich.”
Partner Matt Barton, head of Forresters’ Munich office, added: “I would like to warmly welcome Thomas to our team here in Munich. Thomas is our third senior hire in a matter of months, reflecting our commitment to strengthening the capabilities of our German office. Thomas’ expertise is sure to be a significant asset to our team, as he brings with him a wealth of private practice experience, as well as his valuable insights from working directly within the biotech industry in recent years.”
